Suppr超能文献

复发时间间隔作为乙型肝炎病毒相关肝细胞癌患者挽救性肝移植总体生存的预测指标

Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.

作者信息

Hu Zhenhua, Zhou Jie, Li Zhiwei, Xiang Jie, Qian Ze, Wu Jian, Zhang Min, Zheng Shusen

机构信息

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang Province, China; Key Laboratory of Organ Transplantation, Hangzhou, Zhejiang Province, China.

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang Province, China; Key Laboratory of Organ Transplantation, Hangzhou, Zhejiang Province, China.

出版信息

Surgery. 2015 Feb;157(2):239-48. doi: 10.1016/j.surg.2014.09.018.

Abstract

BACKGROUND

Salvage liver transplantation (SLT) has been proposed for recurrent hepatocellular carcinoma (HCC) after hepatectomy; however, it is unclear how the time interval to tumor recurrence from previous hepatectomy affects prognosis.

METHODS

We analyzed retrospectively the outcomes of 62 patients who underwent SLT in the Liver Transplantation Center of the First Affiliated Hospital of Zhejiang University between 2001 and 2012. SLT recipients were divided into 2 groups based on whether the time interval to recurrence was >1 year (L group) or <1 year (S group).

RESULTS

Baseline characteristics were similar between the 2 groups. The 1-, 3-, and 5-year overall survival rates were 81%, 45%, and 45% in the L group, which were better than in the S group, with 47%, 21%, and 21%, respectively (P = .005). The corresponding tumor-free survival rates were similar (P = .60) between 2 groups, with 71%, 51%, and 41% in the L group versus 55%, 55%, and 55% in the S group. Macrovascular invasion (hazard ratio [HR], 3.30), greatest tumor diameter (HR, 3.92), and time interval to tumor recurrence from previous hepatectomy (HR, 0.29) were independent predictors for overall survival. Furthermore, the diameter of the largest tumor was the only independent predictor of tumor-free survival (HR, 25.64).

CONCLUSION

The time interval to HCC recurrence from a previous hepatectomy is an important factor associated with survival after SLT. This finding should be helpful in guiding patient selection criteria for SLT in patients with previous hepatectomy.

摘要

背景

挽救性肝移植(SLT)已被提议用于肝切除术后复发性肝细胞癌(HCC);然而,从先前肝切除到肿瘤复发的时间间隔如何影响预后尚不清楚。

方法

我们回顾性分析了2001年至2012年期间在浙江大学第一附属医院肝移植中心接受SLT的62例患者的结局。根据复发时间间隔是否>1年(L组)或<1年(S组),将SLT受者分为两组。

结果

两组的基线特征相似。L组的1年、3年和5年总生存率分别为81%、45%和45%,优于S组,S组分别为47%、21%和21%(P = 0.005)。两组的相应无瘤生存率相似(P = 0.60),L组为71%、51%和41%,S组为55%、55%和55%。大血管侵犯(风险比[HR],3.30)、最大肿瘤直径(HR,3.92)以及从先前肝切除到肿瘤复发的时间间隔(HR,0.29)是总生存的独立预测因素。此外,最大肿瘤的直径是无瘤生存的唯一独立预测因素(HR,25.64)。

结论

从先前肝切除到HCC复发的时间间隔是与SLT术后生存相关的重要因素。这一发现应有助于指导先前接受过肝切除的患者进行SLT的患者选择标准。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验